ENZO BIOCHEM INC
DelistedCIK 316253fmd_1ZR3HWMXS4G50KKYRGB0YQXSNTManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Aug 01, 2009 to Apr 30, 2025, 63 periods
Latest annual · FY2024
Millions- Total revenues
- 32
- Gross profit
- 15
- Operating income
- (12)
- Net income
- (26)
- Free cash flow
- (27)
Latest quarter · Q3 FY2025
Millions- Total revenues
- 6
- Gross profit
- 3
- Operating income
- (3)
- Net income
- (3)
- Free cash flow
- (4)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- -35.3%
- Revenue, 5 yearsFY2019 to FY2024
- -17.0%
- Net income, 5 yearsFY2019 to FY2024
- n/m
ENZO BIOCHEM INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $31.9 million | $31.1 million | +2.7% | 10-K 2024-10-29 · proof |
| Gross profit | $14.6 million | $13.2 million | +10.9% | 10-K 2024-10-29 · proof |
| Operating income | -$12.4 million | -$24.7 million | 10-K 2024-10-29 · proof | |
| Net income | -$26.1 million | $20.3 million | -228.5% | 10-K 2024-10-29 · proof |
| Cash from operating activities | -$26.3 million | -$37 million | 10-K 2024-10-29 · proof | |
| Free cash flow | -$26.8 million | -$39.7 million | 10-K 2024-10-29 · proof | |
| Total assets | $85.8 million | $121.9 million | -29.6% | 10-K 2024-10-29 · proof |
| Total liabilities | $29.7 million | $43.4 million | -31.7% | 10-K 2024-10-29 · proof |
| Cash and cash equivalents | $52.4 million | $82.4 million | -36.4% | 10-K 2024-10-29 · proof |
- What was ENZO BIOCHEM INC's revenue in fiscal 2024?
- ENZO BIOCHEM INC reported revenue of $31.9 million for fiscal 2024 (the year ended Jul 31, 2024), against $31.1 million the year before (+2.7%). Source: the 10-K filed with the SEC on Oct 29, 2024. SEC
- What was ENZO BIOCHEM INC's gross profit in fiscal 2024?
- ENZO BIOCHEM INC reported gross profit of $14.6 million for fiscal 2024 (the year ended Jul 31, 2024), against $13.2 million the year before (+10.9%). Source: the 10-K filed with the SEC on Oct 29, 2024. SEC
- What was ENZO BIOCHEM INC's operating income in fiscal 2024?
- ENZO BIOCHEM INC reported operating income of -$12.4 million for fiscal 2024 (the year ended Jul 31, 2024), against -$24.7 million the year before. Source: the 10-K filed with the SEC on Oct 29, 2024. SEC
- What was ENZO BIOCHEM INC's net income in fiscal 2024?
- ENZO BIOCHEM INC reported net income of -$26.1 million for fiscal 2024 (the year ended Jul 31, 2024), against $20.3 million the year before (-228.5%). Source: the 10-K filed with the SEC on Oct 29, 2024. SEC
- What was ENZO BIOCHEM INC's cash from operating activities in fiscal 2024?
- ENZO BIOCHEM INC reported cash from operating activities of -$26.3 million for fiscal 2024 (the year ended Jul 31, 2024), against -$37 million the year before. Source: the 10-K filed with the SEC on Oct 29, 2024. SEC
- What was ENZO BIOCHEM INC's free cash flow in fiscal 2024?
- ENZO BIOCHEM INC reported free cash flow of -$26.8 million for fiscal 2024 (the year ended Jul 31, 2024), against -$39.7 million the year before. Source: the 10-K filed with the SEC on Oct 29, 2024. SEC
- What are ENZO BIOCHEM INC's total assets?
- As of Jul 31, 2024, ENZO BIOCHEM INC reported total assets of $85.8 million, against $121.9 million a year earlier (-29.6%). Source: the 10-K filed with the SEC on Oct 29, 2024. SEC
- What are ENZO BIOCHEM INC's total liabilities?
- As of Jul 31, 2024, ENZO BIOCHEM INC reported total liabilities of $29.7 million, against $43.4 million a year earlier (-31.7%). Source: the 10-K filed with the SEC on Oct 29, 2024. SEC
- What are ENZO BIOCHEM INC's cash and cash equivalents?
- As of Jul 31, 2024, ENZO BIOCHEM INC reported cash and cash equivalents of $52.4 million, against $82.4 million a year earlier (-36.4%). Source: the 10-K filed with the SEC on Oct 29, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:316253&period_type=annual&limit=5"Information only, not investment advice.